Increased CD4 (OS, HR =0.395, p=0.007) and CD4+CD8 (OS, HR=0.478, p=0.013) in tumor TLS were protecting factor for survival, but with limited clinical significance (shown in Table 2). Here, CD8A is linked to neoplasm.